These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1294 related articles for article (PubMed ID: 26762955)

  • 1. Genome Editing and Its Applications in Model Organisms.
    Ma D; Liu F
    Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted genome editing tools for disease modeling and gene therapy.
    Cai M; Yang Y
    Curr Gene Ther; 2014 Feb; 14(1):2-9. PubMed ID: 24665839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic correction using engineered nucleases for gene therapy applications.
    Li HL; Nakano T; Hotta A
    Dev Growth Differ; 2014 Jan; 56(1):63-77. PubMed ID: 24329887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRISPR/Cas9 system for plant genome editing and beyond.
    Bortesi L; Fischer R
    Biotechnol Adv; 2015; 33(1):41-52. PubMed ID: 25536441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery technologies for genome editing.
    Yin H; Kauffman KJ; Anderson DG
    Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant genome engineering in full bloom.
    Lozano-Juste J; Cutler SR
    Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genome-editing: focus on the off-target effects].
    He X; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1757-1775. PubMed ID: 29082723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic editing opens new avenues for zebrafish as a model for neurodegeneration.
    Schmid B; Haass C
    J Neurochem; 2013 Nov; 127(4):461-70. PubMed ID: 24117801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology-Independent Integration of Plasmid DNA into the Zebrafish Genome.
    Auer TO; Del Bene F
    Methods Mol Biol; 2016; 1451():31-51. PubMed ID: 27464799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9.
    LaFountaine JS; Fathe K; Smyth HD
    Int J Pharm; 2015 Oct; 494(1):180-94. PubMed ID: 26278489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
    Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
    Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN.
    Ul Ain Q; Chung JY; Kim YH
    J Control Release; 2015 May; 205():120-7. PubMed ID: 25553825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing comes of age.
    Kim JS
    Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases.
    Hu JH; Davis KM; Liu DR
    Cell Chem Biol; 2016 Jan; 23(1):57-73. PubMed ID: 26933736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted mutagenesis in Zea mays using TALENs and the CRISPR/Cas system.
    Liang Z; Zhang K; Chen K; Gao C
    J Genet Genomics; 2014 Feb; 41(2):63-8. PubMed ID: 24576457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in genome engineering techniques in the silkworm, Bombyx mori.
    Daimon T; Kiuchi T; Takasu Y
    Dev Growth Differ; 2014 Jan; 56(1):14-25. PubMed ID: 24175911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.
    Gaj T; Gersbach CA; Barbas CF
    Trends Biotechnol; 2013 Jul; 31(7):397-405. PubMed ID: 23664777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRISPR-Cas system for plant genome editing: advances and opportunities.
    Kumar V; Jain M
    J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.